Skip to main content
. 2023 Mar 28;12(3):429–444. doi: 10.21037/tp-23-123

Table 1. Basic characteristics of the included studies.

Study (year) Country Type of study Experimental group Control group
Sample size Age, years Sample size Age, years
Kurku, 2019 Turkey Case-control 101 13.2±1.6 18 13.1±2.3
Malecki, 2020 Poland Case-control 16 11.0±2.2 14 10.6±4.5
Kwon, 2020 Korea Case-control 53 10.8±1.3 73 10.8±1.4
Thompson, 2017 USA Case-control 20 13.2±3.1 10 13.8±2.1
Battal, 2018 Turkey Case-control 32 13.3±2.8 24 12.8±3.3
Elkabany, 2020 Egypt Case-control 31 9.98±3.39 49 8.3±2.73
Gupta, 2020 India Case-control 62 10.52±2.2 38 9.32±2.4
Hattar, 2011 USA Case-control 20 12.2±2 17 12.4±2.1
Hu W, 2017 China Case-control 29 10.23±1.35 16 9.72±1.61
Liu F, 2022 China Case-control 48 11.24±0.59 54 10.16±0.48
Antunes, 2013 Brazil Clinical trial 34 13.6±1.1 34 13.6±1.0
Grønbæk H, 2012 Denmark Clinical trial 117 12.3±1.3 117 12.1±1.3
Grønbæk H, 2012 Denmark Clinical trial 71 13.4±1.3 117 12.1±1.3
Koot BG, 2011 The Netherlands Clinical trial 144 14.1±2.3 144 14.1±2.3
Verduci, 2013 Italy Clinical trial 46 6–14 46 6–14
Nier, 2018 Austria Clinical trial 16 7.8±0.3 36 7.3±0.2

Data are shown as number, range, or mean ± standard deviation.